Notification of managers`transactions according to article 19 MAR
Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer
| | | | | | | | |
1 | Details of the person discharging managerial responsibilities/person closely associated |
a) | Name | Sung Lee |
2 | Reason for the notification |
a) | Position/status | Member of the managing body of MorphoSys AG |
b) | Initial notification/Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) | Name | MorphoSys AG |
b) | LEI | 529900493806K77LRE72 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) | Description of the financial instrument. type of instrument Identification code | American Depositary Shares (ADS), CUSIP: 617760202; ratio: 4 ADS = 1 ordinary share of MorphoSys AG (ISIN: DE0006632003) For trade on Nasdaq |
b) | Nature of the transaction | Acquisition |
c) | Price(s) and volume(s) | Price(s) Volume(s)
9.36 US-$ 14,040.00 US-$ |
d) | Aggregated information Aggregated volume
Price |
14,040.00 US-$
9.36 US-$ |
e) | Date of the transaction | 2021-12-03; UTC+1 |
f) | Place of the transaction | Nasdaq |

(1) Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the disclosure thresholds. the competent authority for notifications of delays. the permission for trading
during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).